Position in MRK
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$4,548,257
+$314,170 QoQ
Shares Held
35,395
+0.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.45%
of 13F equity value
Holder Rank
#1,092
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 93%
Shared 0%
None 7%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Palisade Asset Management, LLC holds $93,677,669 across 8 Drug Manufacturers - General names. MRK ranks #5 (4.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
72,776 | $26,353,645 | |
| 2 | JNJ |
Johnson & Johnson
|
100,872 | $25,618,461 | |
| 3 | LLY |
ELI LILLY & Co
|
14,193 | $17,023,511 | |
| 4 | ABBV |
AbbVie Inc.
|
62,276 | $15,671,132 | |
| 5 | MRK |
Merck & Co., Inc.
This page
|
35,395 | $4,548,257 | |
| 6 | NVS |
Novartis AG
|
15,639 | $2,450,944 | |
| 7 | PFE |
Pfizer Inc
|
44,085 | $1,061,566 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
16,490 | $950,153 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,548,257 | 35,395 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $4,234,087 | 35,199 | Shares | Sole | 2026-04-14 | |
| 2025-12-31 | $3,713,993 | 35,284 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,863,943 | 34,123 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $2,706,163 | 34,186 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $2,994,034 | 33,356 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $3,279,955 | 32,971 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $3,101,777 | 27,314 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $3,365,007 | 27,181 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $3,588,512 | 27,196 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $2,967,088 | 27,216 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $2,684,215 | 26,073 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $3,037,295 | 26,322 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $2,735,499 | 25,712 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $2,948,163 | 26,572 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $2,267,281 | 26,327 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $2,364,220 | 25,932 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $2,135,925 | 26,032 | Shares | Sole | 2022-04-21 | |
| 2021-12-31 | $1,772,836 | 23,132 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $1,715,287 | 22,837 | Shares | Sole | 2021-10-25 | |
| 2021-06-30 | $1,710,784 | 21,998 | Shares | Sole | 2021-07-22 | |
| 2021-03-31 | $1,572,405 | 20,397 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $1,982,994 | 24,242 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $1,844,145 | 22,232 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $1,719,201 | 22,232 | Shares | Sole | 2020-07-27 | |
| 2020-03-31 | $1,712,068 | 22,252 | Shares | Sole | 2020-04-24 | |
| No filing history on record for this holder in this stock. | ||||||